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ABSTRACT
Two approved ractopamine hydrochlo-
ride source options currently exist in the 
United States cattle feeding marketplace. 
A study was conducted to evaluate the 
effects of feeding Actogain (Zoetis Inc., 
Florham Park, NJ) relative to Optaflexx 
(Elanco Animal Health, Greenfield, 
IN) or a control diet (no β-adrenergic 
agonist) on growth performance and car-
cass characteristics. Steers (n = 2,083, 
initial BW = 512.2 ± 37.7 kg) were 
slaughtered on 2 separate days; each day 
consisted of 5 blocks and 3 treatments 
per block. Each slaughter group was fed 
for a 35-d period in which Actogain and 
Optaflexx treatments were formulated 
to provide 30 mg/kg of ractopamine 
hydrochloride (DM basis). Data were 
analyzed as a randomized complete block 
design using individual contrast state-
ments to compare between treatments 
when the overall treatment factor was 
significant (P < 0.05). Live performance 
data included BW, ADG, DMI, and 
G:F. Twenty-four hours after slaughter, 
carcass quality and yield attributes were 
evaluated for all carcasses. Cattle fed 
ractopamine hydrochloride (Actogain or 
Optaflexx treatments) had greater (P 
≤ 0.02) BW (+1.5%), ADG (+15%), 
G:F (+17%), HCW (+2%), dressed 
carcass yield (+0.345 percentage points), 
and LM area (+2.4%) concurrent with 
reduced (P ≤ 0.02) DMI (−1.7%). Live 
performance (or carcass-adjusted live 
performance) did not differ (P ≥ 0.33) 
between ractopamine hydrochloride prod-
ucts. Yield grade, 12th rib fat thickness, 
and KPH percentage were not different 
(P ≥ 0.11) among treatments, whereas 
marbling score was reduced (P ≤ 0.01) in 
the Optaflexx (Small39) treatment versus 
control (Small52) or Actogain (Small49) 
treatments. Results of the study demon-
strate that Actogain compared similarly 
to Optaflexx, and both Actogain and 
Optaflexx treatment groups had greater 
growth performance and dressed yield ef-
fects relative to the control group.
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INTRODUCTION
Ractopamine hydrochloride is an 
orally active, β1-adrenergic agonist fed 
to finishing cattle before slaughter. 
β-Adrenergic agonists bind to ad-
renergic receptors on bovine somatic 
cells, increasing protein accretion 
while impeding lipogenesis (Johnson 
and Chung, 2007; Bryant et al., 2010). 
The result of feeding β-adrenergic 
agonist compounds is the partitioning 
of dietary energy away from adipose 
accretion and toward muscle deposi-
tion (Mersmann, 1998; Johnson and 
Chung, 2007), resulting in increased 
growth performance and carcass lean-
ness in finishing cattle (Avendaño-
Reyes et al., 2006; Gruber et al., 
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2007; Scramlin et al., 2010; Boler et 
al., 2012; Arp et al., 2014). In previ-
ous studies, ractopamine hydrochlo-
ride increased final BW (Avendaño-
Reyes et al., 2006; Winterholler et al., 
2007; Winterholler et al., 2008), ADG 
(Avendaño-Reyes et al., 2006; Gruber 
et al., 2007; Winterholler et al., 2008) 
and G:F (Avendaño-Reyes et al., 
2006; Gruber et al., 2007) relative to 
diets not containing β-adrenergic ago-
nists. Accordingly, carcass characteris-
tics responded to ractopamine feeding 
with increased dressed carcass yield 
(Avendaño-Reyes et al., 2006) and 
HCW (Avendaño-Reyes et al., 2006; 
Winterholler et al., 2008), leaner yield 
grade distributions (Gruber et al., 
2007; Winterholler et al., 2008), and 
decreased marbling scores (Gruber et 
al., 2007; Winterholler et al., 2008). 
Therefore, ractopamine hydrochloride 
can provide economic value to finish-
ing cattle via live performance and 
carcass weight and yield improve-
ments.
Currently, 2 ractopamine hydrochlo-
ride β1-adrenergic agonist products 
are available in the United States, 
Optaflexx (Elanco Animal Health, 
Greenfield, IN), marketed since 2003, 
and Actogain (Zoetis, Kalamazoo, 
MI), marketed since 2014. Previous 
literature has reported linear improve-
ments to final BW, ADG, and G:F 
when ractopamine hydrochloride was 
fed daily at 0 to 200 mg per animal 
(Abney et al., 2007) and improve-
ments to HCW and LM area when 
ractopamine hydrochloride was fed 
daily at increasing levels from 0 to 
400 mg per animal (Arp et al., 2014). 
Increasing the duration of ractopa-
mine feeding from 28 to 42 d has also 
resulted in positive linear effects on 
ADG and G:F (Abney et al., 2007). 
Therefore, daily doses of 300 to 400 
mg per animal daily for longer than 
the minimum label duration of 28 
d could maximize economic return 
to producers. To date, consider-
able research has been conducted on 
Optaflexx; however, minimal data 
exists comparing Actogain to con-
trol diets or to Optaflexx on feedlot 
finishing performance and carcass 
characteristics. Therefore, the objec-
tives of this study were to elucidate 
differences in the growth performance 
and carcass characteristics of cattle 
fed Actogain versus Optaflexx at 300 
mg/head for 35 d before slaughter, 
relative to a control diet.
MATERIALS AND METHODS
Animal Management
The feeding portions of this experi-
ment were conducted in the Cactus 
Research pens at Wrangler Feedyard 
(Tulia, TX). All experimental proce-
dures followed the guidelines de-
scribed in the Guide for the Care and 
Use of Agricultural Animals in Agri-
cultural Research and Teaching (FASS, 
Champaign, IL), and prior approval 
was granted by the Zoetis ethical 
review board (Zoetis) for all animal 
procedures.
Steers were selected from a pool of 
candidate animals on feed at Wran-
gler Feedyard. Originally, steers 
arrived at Wrangler Feedyard from 
multiple sources between October 12, 
2013, and December 5, 2013. Upon 
feedyard arrival, all steers were com-
mingled across source and assigned 
to pens (29 to 263 animals per pen) 
based on BW, uniformity, and esti-
mated days to finish. At arrival, all 
steers were vaccinated with Vista 3 
(Merck Animal Health, Summit, NJ) 
for infectious bovine rhinotracheitis 
and bovine viral diarrhea types 1 and 
2, implanted with either Revalor-S 
(120 mg of trenbolone acetate + 24 
mg of estradiol) or Revalor XS (200 
mg of trenbolone acetate + 40 mg 
of estradiol; Merck Animal Health) 
depending on estimated days to finish 
(implant status was uniform within 
a block), assigned a unique individu-
ally numbered ear tag, and given an 
anthelmintic treatment of Dectomax 
injectable (Zoetis).
Experimental Design
This study was designed as a 
randomized complete block with a 
one-way treatment structure repli-
cated in 2 slaughter groups. Steers for 
the study were selected before study 
initiation. Selection criteria included 
animals that were clinically healthy, 
uniform in body conformation, and 
indicative of typical United States 
southern plains cattle (medium to 
large frame British × Continental 
crossbred steers); BW ranged from 
431 to 596 kg. Cattle were selected for 
both slaughter groups from the can-
didate steer pool (d −41 to −39 for 
group 1 and d −52 to −50 for group 
2) by allotting the initial candidate 
steers housed in 210 animal pens 
to blocks of three 70-animal pens, 
of equal average weight, for a total 
of 30 pens. Pen BW were stratified 
from heaviest to lightest based on 
candidate mean BW; each succeeding 
group of 3 pens constituted a block. 
Within each block of 3 pens, treat-
ment was randomly assigned so that 
each treatment group was represented 
in each block. Accordingly, each 
slaughter group had 5 blocks with 
each block containing all 3 treatments 
of Actogain, 30 mg/kg of diet DM 
(Zoetis Inc.); Optaflexx, 30 mg/kg of 
diet DM (Elanco Animal Health); and 
control, no ractopamine (n = 10 pens 
per treatment). At selection, individu-
al BW was taken on a scale calibrated 
to ±0.45 kg accuracy. The scale was 
check weighed with 454 kg of certi-
fied weights before weighing, and the 
scale was tared to zero as needed be-
tween steers. In addition, steers were 
weighed on certified pen scales as 2 
groups per pen on d 0 (before feed-
ing) and on d 35 (before shipment for 
slaughter) with all 3 pens per block 
weighed consecutively. Pen weights 
were used to determine performance 
(ADG, G:F, BW) for all treatments.
Diet, Feeding, and Treatments
After randomization, cattle re-
mained in designated pens for the 
duration of pretreatment (17 to 22 
d for slaughter group 1 and 33 to 38 
d for slaughter group 2) and treat-
ment (35 d for both slaughter groups) 
phases. Soil surfaced experimental 
pens (18.3 m wide × 52.4 m deep) 
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were outdoors with natural light-
ing (normal seasonal duration) and 
ventilation. Pens provided 13.7 m2 
of surface space and 0.25 m of linear 
bunk space per animal. Water was 
available in each pen at all times. 
Steers were fed a finishing diet during 
the pretreatment period and treat-
ment period that met or exceeded 
NRC (1996) requirements. A basal 
nonmedicated diet contained (DM 
basis) 63.3% steam flaked corn, 17.0% 
wet distillers grains with solubles, 6% 
sorghum silage, 6.0% chopped corn 
stover, 2.7% condensed corn distill-
ers solubles, 1.4% animal fat, and 
3.6% finisher supplement that was 
prepared daily in the feedyard mill 
equipped with a computerized batch-
ing system (Micro Beef Technologies, 
Amarillo, TX). Actogain treatment 
was fed as Actogain 45 Type A (100 
g/kg), whereas Optaflexx was fed as 
Optaflexx 45 Type A (100 g/kg), with 
both added to each load of feed using 
a water-flush, microingredient delivery 
system to ensure 30.1 mg/kg of rac-
topamine hydrochloride per kilogram 
of feed (DM basis). The concentra-
tion of ractopamine hydrochloride in 
both Actogain and Optaflexx treated 
diets was to target a daily dose of 300 
mg of ractopamine hydrochloride per 
head. Monensin and tylosin (Rumen-
sin and Tylan, respectively; Elanco 
Animal Health) were removed from all 
3 dietary treatments during the treat-
ment phase of the study. Inventory 
reports and microingredient records 
pertaining to daily β-AA feeding were 
retained and reviewed to ensure the 
appropriate concentration dose for 
Actogain and Optaflexx treatments 
was maintained throughout the trial.
Feed was delivered 3 times per day 
to each pen using a truck equipped 
with load cells, with the quantity de-
livered per pen recorded electronically 
at each feeding. Feed was delivered in 
quantities sufficient to ensure ad libi-
tum intakes; bunks were managed to 
ensure all feed delivered in a day was 
consumed. No weighback of orts due 
to adverse weather events or poor feed 
condition occurred during the study. 
Daily samples of each experimental 
diet were collected and analyzed for 
DM. Additionally, daily feed samples 
from each treatment feed were kept 
frozen and composited weekly. Weekly 
study ration samples were obtained 
before the start of the trial and for 
the duration of study and analyzed 
for nutrient composition by a com-
mercial laboratory in Amarillo, Texas 
(Servi-Tech Labs; 59.8% DM, 15.0% 
CP, 2.7% NPN, 12.1% ADF, 19.6% 
NDF, 6.3% ether extract, 0.70% Ca, 
0.38% P, 0.20% Mg, 0.70% K, and 
0.19% S). Composited weekly feed 
samples (n = 7 per treatment) were 
also assayed for ractopamine levels 
for both Actogain and Optaflexx 
treatments, with 78.8 and 79.7% of 
ractopamine analyzed as a percentage 
of formulation, respectively. Although 
these concentrations were lower than 
the targeted values, they were con-
sistently within the normal range of 
recovery reported for standard racto-
pamine assays for commercial testing.
Health Assessment
Daily visual assessment of health 
was performed by trained pen riders 
who were blinded to treatment. Any 
health issues and mortality incidents 
were investigated by trained Cactus 
Research personnel.
Carcass Evaluation
At slaughter, individual ear tag, 
assigned beef processor identification 
number, and HCW were recorded. 
Twenty-four hours after slaughter, a 
detailed carcass evaluation was con-
ducted by trained personnel from the 
Beef Carcass Research Center (West 
Texas A&M University, Canyon) who 
were blinded to treatments. Carcass 
evaluation included marbling score, 
lean and skeletal maturity, 12th rib 
s.c. fat depth (cm) using a USDA 
preliminary YG ruler, LM area (cm2) 
using a reverse blot image technique, 
and estimated percentage of KPH. 
Final QG and calculated YG were 
determined (USDA, 1997).
Statistical Analysis
Average shrunk pen weights (4% 
pencil shrink) were analyzed using 
a general linear mixed model for re-
peated measures with fixed effects of 
treatment, time point, and treatment 
× time point interaction and ran-
dom effects of slaughter group, block 
within slaughter group, block within 
slaughter group × treatment inter-
action, and error. Treatment least 
squares means and 95% confidence 
intervals were calculated. If either 
the treatment or treatment × time 
point interaction was significant, then 
treatment contrasts were determined 
at each time point. Average daily 
gain (deads-out, pencil shrunk pen 
weights), gain efficiency (deads-out, 
pencil shrunk pen weights), ADFI, 
carcass-adjusted final BW, carcass-
adjusted ADG, carcass-adjusted 
G:F, HCW, USDA calculated YG, 
marbling score, dressed carcass yield, 
12th rib s.c. fat thickness, LM area, 
and KPH percentage were analyzed 
using a general linear mixed model 
with the fixed effect of treatment 
and the random effects of slaughter 
group, block within slaughter group, 
and error. Treatment least squares 
means and 95% CI were determined. 
If the overall treatment effect was 
significant, then treatment contrasts 
of control versus Actogain, control 
versus Optaflexx, and Actogain versus 
Optaflexx were determined. Carcass 
weight was the primary response vari-
able of interest in this study. Based 
on previous research at this study 
site, historical SE values with respect 
to carcass weight were used for power 
calculations in the current study. 
The 10 replicates for the study were 
determined using the experimental 
model for this research site, with a 
single df contrast and multiple itera-
tions between absolute difference in 
carcass weight and replicate number 
(0.05 significance level and 80% power 
of the test).
For USDA QG, the percentages of 
carcasses per pen that graded Choice 
or better (vs. Select and standard) 
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were analyzed separately using a 
generalized linear mixed model with a 
binomial error distribution and a logit 
link function.
RESULTS AND DISCUSSION
Morbidity, Mortality,  
and Removals
On d 0, 2,083 animals remained 
from the original 2,100 selected. From 
d 0 to 35, 5 steers died because of 
bloat as defined by a necropsy admin-
istered by trained Cactus Research 
personnel and elimination of other 
causative factors. Four of the 5 steers 
were in the Optaflexx treatment 
group (all in the second slaughter 
group), and 1 of the 5 steers was in 
the Actogain treatment (first slaugh-
ter group). Three steers were removed 
from the trial, one steer in the control 
treatment (second slaughter group) 
for lameness and 2 steers in the 
Optaflexx group for presumed hard-
ware disease and presumed atypical 
interstitial pneumonia as diagnosed 
by trained Cactus Research personnel.
Growth Performance
Actogain and Optaflexx resulted 
in greater BW gain by 9.0 and 9.5 
kg, respectively (P < 0.01; 633.2 and 
633.5 kg vs. 624.2 kg) over control 
fed steers (Table 1). Ractopamine 
hydrochloride increased final BW 
in previous studies by 10.6 to 12 kg 
(Avendaño-Reyes et al., 2006; Win-
terholler et al., 2007; Winterholler 
et al., 2008). Average daily gain was 
increased (P < 0.01) in the current 
study by 14.5 and 15.8% by feed-
ing Actogain or Optaflexx, respec-
tively, over control diets in the last 
35 d. Results from the present study 
compare with those reported by 
Avendaño-Reyes et al. (2006), who 
observed ADG to increase 31.6% 
during the last 33 d of the finishing 
period in steers fed Optaflexx at 300 
mg/head daily, whereas Gruber et al. 
(2007) and Winterholler et al. (2008) 
observed 15.3 and 46.3% increases in 
ADG, respectively, in steers fed rac-
topamine at 200 mg/head daily for 28 
d. Dry matter intake was reduced (P 
≤ 0.02) by ractopamine hydrochloride 
treatment from 11.14 kg/d for control 
fed cattle to 10.96 kg/d for Actogain 
treated steers and 10.95 kg/d for 
Optaflexx treated steers. As a re-
sult, G:F was increased (P < 0.01) 
in steers fed Actogain or Optaflexx 
over steers fed the control diet by 16.2 
and 18.2%, respectively. Gruber et al. 
(2007) reported G:F to increase simi-
lar to the current study from 0.145 to 
0.170 over the last 28 d of the finish-
ing period, and Avendaño-Reyes et al. 
(2006) also reported a G:F improve-
ment from 0.185 for control cattle 
to 0.248 with ractopamine feeding. 
Results from the current study il-
lustrate similar improvements in live 
performance for both Actogain and 
Optaflexx treated groups over control 
steers. Moreover, the live growth per-
formance response to ractopamine did 
not differ (P ≥ 0.33) between sources 
and is similar to previously published 
reports.
Carcass-adjusted live performance 
of both ractopamine hydrochloride 
treatment groups was greater (P < 
0.01) relative to the control. Final 
carcass-adjusted BW increased from 
Table 1. Effects of ractopamine hydrochloride1 (Actogain or Optaflexx; 300 mg/head per d) versus control on 
growth performance of finishing steers
Item Control (C) Actogain (A) Optaflexx (O) SEM P-value
Significance of contrast
C vs. A C. vs. O A vs. O
Live performance         
 Pens, No. 10 10 10      
 Cattle,2 No. 693 695 695      
 Days on feed 35 35 35      
 Initial BW,3 kg 566.4 566.9 566.1 7.236 <0.01 0.74 0.83 0.59
 Final BW,3 kg 624.2 633.2 633.5 <0.01 <0.01 0.81
 ADG,3 kg/d 1.65 1.89 1.91 0.034 <0.01 <0.01 <0.01 0.41
 DMI, kg/d 11.14 10.96 10.95 0.151 0.02 0.02 0.01 0.87
 G:F 0.148 0.172 0.175 0.003 <0.01 <0.01 <0.01 0.33
Carcass-adjusted live performance4       
 Final BW, kg 622.1 634.3 634.7 3.636 <0.01 <0.01 <0.01 0.81
 ADG, kg/d 1.59 1.93 1.96 0.026 <0.01 <0.01 <0.01 0.39
 G:F 0.143 0.175 0.179 0.001 <0.01 <0.01 <0.01 0.33
1Actogain, Zoetis Inc. (Florham Park, NJ); Optaflexx, Elanco Animal Health (Greenfield, IN).
2Numbers of cattle reflect end of trial numbers; all performance data are representative of deads-out data.
3Initial BW, final BW, and ADG are shrunk 4%.
4Carcass-adjusted performance calculated on a pen basis (HCW pen mean/dressed carcass yield mean of all treatments).
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622.1 kg in control steers to 634.3 
kg for Actogain treated steers (P 
< 0.01) and 634.7 kg in Optaflexx 
treated steers (P < 0.01). Carcass-
adjusted ADG increased (P < 0.01) 
with ractopamine supplementation 
from 1.59 kg/d to 1.93 and 1.96 kg/d 
for control steers versus Actogain and 
Optaflexx treatments, respectively. 
Carcass-adjusted G:F increased from 
0.143 in the control group to 0.175 
for Actogain treated steers (P < 0.01) 
and 0.179 for Optaflexx treated steers 
(P < 0.01). Results from the current 
study are similar to ADG and G:F 
carcass-adjusted performance vari-
ables reported by Griffin et al. (2009) 
in the last 29 d of feeding Optaflexx 
to heifers. Carcass-adjusted live 
growth performance did not differ (P 
≥ 0.33) between ractopamine hydro-
chloride sources.
Carcass Characteristics
Carcass attributes including dressed 
yield, HCW, and LM area were in-
creased by ractopamine hydrochloride 
treatment (Table 2). Dressed carcass 
yield increased (P = 0.02) with both 
Actogain and Optaflexx treatment 
from 64.31% for the control steers 
to 64.65 and 64.66%, respectively. 
Ractopamine supplementation also 
resulted in heavier HCW (P < 0.01) 
over control steers, with Actogain 
and Optaflexx steers having HCW 
of 409.4 and 409.6 kg, respectively, 
versus 401.5 kg for control steers. 
Results from the current study are 
similar to the 10.0-kg improvement 
in HCW reported by Winterholler et 
al. (2008). Additionally, LM area was 
increased 2.2 to 2.6% (P < 0.01) from 
91.4 cm2 for control steers to 93.4 and 
93.8 cm2 for Actogain and Optaflexx 
treated steers. Previous literature has 
reported similar increases in LM area 
of 3.3 cm2 (Gruber et al., 2007), 2.1 
cm2 (Bass et al., 2009), and 4.0 cm2 
(Boler et al., 2012). In the current 
study marbling score was reduced 
(P ≤ 0.01) by Optaflexx treatment 
(43.9; Small39) relative to the control 
(45.2; Small52) treatment, whereas the 
Actogain treatment (44.9; Small49) 
was similar to control. Because the 
2 ractopamine products are chemi-
cally equivalent, this outcome was 
unexpected and likely indicative of 
a type I error. Previous literature 
(Gruber et al., 2007; Winterholler et 
al., 2008) reported decreased marbling 
scores concomitant with ractopa-
mine hydrochloride supplementation 
when compared with negative con-
trols regardless of different biological 
types and conventional versus natural 
management systems. Aside from the 
unexpected marbling score outcome, 
carcass characteristics were not differ-
ent (P ≥ 0.49) between ractopamine 
hydrochloride sources.
IMPLICATIONS
Results from the current study 
indicate that either Actogain or 
Optaflexx can be fed in finishing steer 
diets with subsequent improvements 
to live growth performance and car-
cass yield characteristics.
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